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Abstract
Background: Motor system excitability is based on a complex interaction of excitatory and
inhibitory processes, which in turn are modulated by internal (e.g., volitional inhibition) and
external (e.g., drugs) factors. A well proven tool to investigate motor system excitability in vivo is
the transcranial magnetic stimulation (TMS). In this study, we used TMS to investigate the effects
of methylphenidate (MPH) on the temporal dynamics of motor system excitability during a go/nogo
task.
Methods: Using a double-blind, placebo-controlled, crossover design, 14 healthy adults (8 male, 6
female; aged 20–40 yrs) performed a spatial go/nogo task (S1-S2 paradigm) either under dl-
methylphenidate (MPH, 20 mg) or placebo. TMS single and double-pulses (interstimulus interval: 3
ms) were delivered either at 120, 230 or 350 ms after the S2 stimulus (control, go and nogo trials).
Results: At the performance level, faster reaction times and a trend towards less impulsivity
errors under MPH vs. placebo were observed.
In nogo trials, i.e., when a prepared response had to be inhibited, motor evoked potentials (MEPs)
had a smaller amplitude at an interval of 230 ms compared to 120 and 350 ms. The short-interval
intracortical inhibition (SICI) increased over time.
Under MPH, SICI in nogo trials was larger compared to placebo. With the interval between S2 and
the TMS-pulse increasing, MEP amplitudes increased under MPH in nogo trials but an early
inhibitory effect (at 120 ms) could also be observed.
Conclusion: Our results show a distinct pattern of excitatory and inhibitory phenomena in a go/
nogo task. MPH appears to significantly alter the dynamics of motor system excitability. Our
findings suggest that a single dose of 20 mg MPH provides some fine-tuning of the motor system in
healthy adults.
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Background
Motor system excitability is based on a complex interac-
tion of excitatory and inhibitory processes [1]. Over the
last two decades, transcranial magnetic stimulation (TMS)
has proven to be an appropriate tool to study motor sys-
tem excitability in neurological disorders [2] and psychi-
atric disorders [3,4] but also to study the effects of CNS
active drugs [5].
Among the TMS procedures is the double-pulse paradigm
first described by Kujirai et al. [6]: The basic principle
involves the application of two TMS stimuli via the same
coil. The intensity of the first stimulus is set below and the
second one above the motor threshold (MT). If the inter-
stimulus interval (ISI) is between 6 and 25 ms, intracorti-
cal facilitation (ICF) occurs, i.e., the MEP amplitude
measured at the target muscle is larger than for a single
supra-threshold stimulus. If the ISI is set to 1–5 ms, the
opposite effect emerges. The MEP response is inhibited,
so-called short-interval intracortical inhibition (SICI)
occurs. If both pulses are above the MT and the ISI is
between 50 and 200 ms, two MEPs are elicited, with the
second one of a smaller amplitude (long-interval intracor-
tical inhibition, LICI) [7].
Different interneuronal networks in the motor cortex
account for these intracortical excitability phenomena
which are affected differentially by neuromodulators
(e.g., dopamine, noradrenaline) [1,5].
In children with attention-deficit hyperactivity disorder
(ADHD), a decrease in SICI was reported in several studies
[8-10] probably reflecting a neurophysiological correlate
of motor hyperactivity and an inhibitory deficit in these
children, respectively. In adult patients with ADHD, a
reduced SICI was also found [11,12]. Methylphenidate
(MPH), a dopamine-/noradrenaline reuptake inhibitor,
which is considered as first-line treatment, enhances SICI
in children with ADHD [8] with effects being correlated
with clinical improvements [10].
For healthy adults, opposite effects of a single dose of
MPH (10 mg) on intracortical excitability were described
[13]. ICF was enhanced with SICI being unchanged. How-
ever, dosage or genetic factory may influence the results
[14-16].
Motor system excitability cannot only be studied with
subjects at rest, but also while performing a motor control
task [1]. Motor (movement) control is associated with dif-
ferent excitatory and inhibitory effects so that it may be
compared with a car with gas and brake pedals [17]. In a
reaction task for example, excitability in the area project-
ing to the agonist muscle increased just before the move-
ment as reflected by larger amplitudes to TMS single-pulse
responses. Showing a different time course, the SICI
decreased continuously before the start of EMG activity,
from 60 ms before EMG onset, even facilitation is possible
[18,19]. Leocani et al. described a bilateral reduction of
MEP amplitudes to single pulses in nogo trials of a go/
nogo task at a time corresponding to the mean reaction
time in go trials. Since this inhibitory effect also occurred
on the side not to be moved, this finding indicates that
suppression of movement is an active process [20].
Sohn et al. demonstrated that SICI increased under voli-
tional inhibition in a go/nogo task [21]. Thus, SICI may
play a role in providing nonselective suppression of vol-
untary movement in addition to focusing the subsequent
excitatory drive to produce the intended movement.
MPH may affect the interplay of excitatory and inhibitory
processes during a response inhibition task. The aim of
this study was to address this issue in healthy adults, using
a double-blind, placebo controlled, crossover design. We
were specifically interested how overall excitability and
SICI develop over time (350 ms poststimulus) when a
prepared response has to be inhibited and how these tem-
poral dynamics are modulated by MPH.
Methods
Subjects
14 subjects (8 male, 6 female; aged 20–40 yrs) without
neurological or psychiatric impairments, psychotropic
medication and cardiac arrhythmia took part in our study.
12 subjects were right-handed, two males were left-
handed. The study was conducted in accordance with the
Declaration of Helsinki. All subjects gave their written
informed consent to participate in the study, which was
approved by the Ethics Committee of the University of
Erlangen-Nürnberg.
Procedure
The study drug (dl-methylphenidate, MPH, 20 mg or pla-
cebo) was administered orally in a randomized, balanced
order. The two measurements were done at the same time
of day one week apart. 60 min after intake of either pla-
cebo or MPH, the TMS resting motor threshold was deter-
mined. The go/nogo task started 70 min after intake of
medication and lasted for about 50 min.
Subjects were seated 100 cm in front of a 17" monitor
connected with a personal computer. As input device an
apparatus was used that recognized spreading of the fin-
gers via a plastic loop connected with a switch (see Fig. 1)
and transmitted the data via a circuit board of a customary
usb-keyboard (analogous pressing keys "r" for the right
hand, respectively "l" for the left one).Behavioral and Brain Functions 2009, 5:12 http://www.behavioralandbrainfunctions.com/content/5/1/12
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TMS
During the experiment single- and paired-pulse TMS was
applied using a figure-of-eight coil (diameter of one wing
= 70 mm) connected to a Magstim® Bistim unit with two
Magstim® 2002 stimulators (Magstim, Whitland, UK).
The optimal stimulation position was determined over
the left motor cortex to elicit motor evoked potentials
(MEPs) of the m. abductor digiti minimi of the right
hand. Resting motor threshold (RMT) was defined as the
minimal stimulus intensity that did not elicit a motor
evoked potential of more than 50 μV in five consecutive
trials in the resting target muscle. The inter-stimulus-inter-
val (ISI) of the paired pulses was set to 3 ms.
The suprathreshold stimulus intensity was adjusted (10–
15% above resting motor threshold) so that the MEP
amplitude was about 1 mV (peak-to-peak), the condition-
ing stimulus intensity was set to 75% of RMT.
EMG recording
EMG recordings were made from the abductor digiti min-
imi muscle of both hands with the recording of the left
hand serving as artefact control. Ensuring a comfortable
posture to minimize EMG artefacts, both forearms were
supported by armrests. EEG was recorded simultaneously
but these data will not be reported here.
A Brainamp® recording system (standard Brainamp ampli-
fier; Brainproducts, Gilching, Germany) was used for data
acquisition (bandwidth: 8–1000 Hz, sampling frequency:
5 kHz).
Go/nogo task and TMS conditions
Presentation®  (Version 11.0; Neurobehavioral Systems,
Albany, CA, USA) was used for the presentation of the go/
nogo-task and for the synchronized triggering of the mag-
netic stimulators. The task consisted of five experimental
blocks with 60 trials per block. Each trial started with the
presentation of a cue stimulus ("S1", 250 ms duration),
which was followed, after an interval of 1500 ms, by a sec-
ond stimulus ("S2", 250 ms duration; see Fig. 2). The
intertrial interval (S1 – S1) was 5500 ± 500 ms. S1 was
either an arrow pointing to the left, one pointing to the
right or – as a control stimulus- a horizontal line. S2 was
either a green check (go-signal), a red cross (nogo-signal)
or a yellow circle (control-condition). The direction of the
arrows instructed the participant which hand to spread in
reaction to a go-signal coming up as S2. Thus, there were
five different task trials (control, go-left, go-right, nogo-
left, nogo-right; equal probability).
TMS was always applied over the left motor cortex and
MEPs were always recorded at the m. abductor digiti min-
imi of the right hand. In the terms "go-left", "go-right" etc.
side determines the hand associated with a task response.
To introduce some time pressure and to enhance the task
difficulty, respectively, participants received a monetary
reward (6 cent per trial) for correct responses in the go tri-
als which occurred within 350 ms after the S2 stimulus. In
case of a wrong reaction, the same amount of money was
subtracted.
Device to register reactions Figure 1
Device to register reactions. Device to register reactions (spreading of the hand with the m. abductor digiti minimi 
involved). left side: switch open, right side: switch closed.Behavioral and Brain Functions 2009, 5:12 http://www.behavioralandbrainfunctions.com/content/5/1/12
Page 4 of 10
(page number not for citation purposes)
Illustration of the go/nogo task (S1-S2 paradigm) Figure 2
Illustration of the go/nogo task (S1-S2 paradigm). The go/nogo task consisted of control, go-left, nogo-left, go-right and 
nogo-right trials. TMS stimuli (single pulses or double pulses with an interstimulus interval of 3 ms) were presented either at 
120 ms, 230 ms or 350 ms after the onset of the S2 stimulus. The EMG traces, which were recorded during control trials, con-
tain the TMS stimulus artefacts and the motor evoked potentials (MEP) elicited by the TMS stimulus.
. . .
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To get familiar with the task including the TMS stimulus
which could interfere with the task completion, short
practice blocks were introduced. In four of the five exper-
imental blocks TMS was applied. The block without TMS
varied randomly between the second and the fourth
block.
In each trial of the TMS blocks, either a single-pulse or a
double-pulse TMS stimulus was applied. TMS stimuli
occurred at a latency of 120, 230 or 350 ms after the S2
stimulus. So, there were 30 different task × TMS condi-
tions. In each block, there were two trials of a task × TMS
condition (e.g., nogo-left trial × TMS single pulse at a
latency of 230 ms). The order of the different task × TMS
conditions varied randomly across task blocks.
Data processing and analysis
The recorded EMG data were subdivided into segments
with one segment per trial. Only trials with correct behav-
ioral response were processed. For each trial, two peak
detections were processed: One, within a window of 100
ms duration, starting 100 ms before the magnetic pulse to
detect initial tension of the muscle of either hand. Trials
with an initial EMG activity larger than 50 μV were
excluded. The second peak detection was processed to
determine the maximum MEP amplitude (peak-to-peak).
MEP amplitudes larger than 3000 μV and smaller than 50
μV were also not considered for further analysis. So far,
there is no standard procedure how to analyze TMS data
which are recorded during a response inhibition task. If
intracortical excitability is measured at rest, only sub-
blocks with unconditioned MEPs in the range of 500–
1500 μV are usually considered [e.g., [10]]. For the analy-
sis of response inhibition tasks, a different strategy has to
be applied. We decided to use the upper and lower limits
mentioned above in order to eliminate extreme values
which are rather due to artefacts or technical reasons.
The mean amplitude for each task × TMS condition was
calculated. Since MEP amplitudes of two different meas-
urements were compared, absolute MEP amplitudes can
hardly be used. Therefore, relative MEP amplitudes were
calculated with the arithmetic mean of the single pulse
MEPs of the particular control condition being defined as
100 percent.
In go-right trials, mean reaction time was about 320 ms
(see Table 1). EMG activity started about 90 ms earlier
before a reaction was triggered and registered. Also taking
the MEP latency of about 20 ms after the TMS stimulus
into account, it is obvious that EMG activity was present
in most of the go-right trials when TMS was applied 230
ms or 350 ms after S2. So, go-right trials with these TMS
latencies were not further analyzed.
Statistical analysis
Data are presented as means ± SD in the text.
Hits (correct responses in go trials) and impulsivity errors
(responses in nogo trials) were subjected to an ANOVA
with the order of drug administration as between-subject
factor and medication (Med, placebo vs. MPH) as within-
subject factor. To differentiate between left-hand and
right-hand responses, an additional within-subject factor
side was considered for the analysis of mean reaction
times and the standard deviation of reaction times. Mean
reaction time of the blocks with TMS were compared to
the block without TMS in order to check if performance
was affected by the TMS stimulus.
According to previous TMS studies dealing with response
inhibition tasks [19-21], control, go and nogo trials were
analyzed separately. For the control and go-left condition,
normalized MEP amplitudes were subjected to an ANOVA
with one between-subject factor 'Order' and three within-
subject factors 'Medication' (Med, placebo vs. MPH),
'Latency' (120 ms, 230 ms, 350 ms) and 'Pulse' (single vs.
double-pulse stimulation).
The main focus of the analysis was on nogo trials for
which an additional within-subject factor 'Side' (left vs.
right) was introduced. Since we were particularly inter-
Table 1: Performance results.
Placebo
Mean ± SD
MPH
 Mean ± SD
ANOVAs (significant results)
Hit rate (in %) 98.1 ± 1.8 98.6 ± 1.5
Impulsivity errors 1.07 ± 1.14 0.57 ± 0.65 Med: F(1,12) = 3.27; p < 0.1
Mean reaction time
left hand (in ms) 335.3 ± 16.5 327.4 ± 16.2 Med: F(1,12) = 4.71; p < 0.05
Med × Order: F(1,12) = 10.43; p < 0.01
right hand (in ms) 320.2 ± 15.0 313.4 ± 15.9 Side: F(1,12) = 27.26; p < 0.001
Reaction time – standard deviation
left hand (in ms) 39.3 ± 6.5 36.1 ± 7.2
right hand (in ms) 38.8 ± 5.8 37.6 ± 10.0
Hit rate, impulsivity errors and reaction times were examined.
Factors in the ANOVAs were type of medication (placebo vs. MPH, 'Med'), the order of medication (MPH at the first vs. the second testing, 
'Order') and the reacting hand ('Side').Behavioral and Brain Functions 2009, 5:12 http://www.behavioralandbrainfunctions.com/content/5/1/12
Page 6 of 10
(page number not for citation purposes)
ested in the temporal development of the MEP ampli-
tudes, we conducted trend analyses in case of significant
effects containing the factor latency. Thus, it could be
determined whether the TMS measures show a linear or a
quadratic behaviour from 120 ms, 230 ms to 350 ms. For
simplicity, only trend scores are reported here.
In case of a significant interaction effect containing the
factor Pulse, we additionally calculated ANOVAs with the
standard SICI measure (ratio of conditioned and uncon-
ditioned MEP response).
Degrees of freedom were adjusted with Greenhouse
Geisser correction where appropriate. SPSS for Windows
(version 16.0) was used for statistical analysis.
Results
Performance measures
All participants coped well with the go/nogo-task. Per-
formance results are summarized in Table 1.
Hit rate did not differ significantly between MPH and pla-
cebo condition (MPH: 98.6 ± 1.5%; placebo: 98.1 ± 1.8%,
factor Med: F(1, 12) = 1.71, n.s.).
Impulsivity errors, i.e., reacting despite of a nogo-stimu-
lus, were low but a trend for fewer impulsivity errors
under MPH was obtained (MPH: 1.07 ± 1.14, placebo:
0.57 ± 1.65; factor Med: F(1,12) = 3.27, p < 0.1).
Under MPH, subjects reacted slightly, but significantly
faster in go trials (MPH: 320.4 ± 11.7 ms; placebo: 327.8
± 13.5 ms; factor Med: F(1,12) = 4.71, p < 0.05). We
obtained a significant Med × Order effect indicating that
subjects had shorter reaction times when performing the
task for the second time (first testing: 329.3 ± 12.0 ms, sec-
ond testing: 319.4 ± 15.6 ms; F(1,12) = 10.43, p < 0.01).
Right-hand responses were significantly shorter than left-
hand responses (left-hand reactions: 331.4 ± 14.0 ms;
right-hand reactions: 317.4 ± 11.7 ms; factor Side: F(1,12)
= 27.26, p < 0.001). For the standard deviation of reaction
times, no significant effect concerning medication was
found (F(1,12) = 2.15, n.s.).
Mean reaction time in the task block without TMS was not
significantly different compared to the blocks were TMS
was applied (block w/o TMS: 324.8 ± 5.0 ms; blocks with
TMS: 324.3 ± 4.5 ms; F(1,12) = 0.05, n.s.).
TMS measures
Data from two subjects had to be excluded because too
many trials were rejected by the artifact procedure.
No significant differences between MPH and placebo
were found for the resting motor threshold (MPH: 45.6 ±
8.7% of maximum stimulator output, placebo: 45.7 ±
6.6%; F(1,10) = 0.01, n.s.) and the mean MEP amplitude
in control trials (MPH: 1.04 ± 0.50 mV, placebo: 0.98 ±
0.44 mV; F(1,10) = 0.07, n.s.).
In Fig. 3, the course of the relative amplitudes of uncondi-
tioned and conditioned MEPs is presented for control, go
and nogo trials.
Analyzing the normalized data of the control condition,
the only effect of statistical significance concerned the fac-
tor Pulse (F(1,10) = 155.4; p < 0.001) indicating that
unconditioned MEPs were larger than conditioned MEPs
(see Fig. 3, upper trace). The factor Pulse was also signifi-
cant for go-left, go-right and nogo trials (F(1,10) > 16.86,
p < 0.005).
In go-left trials (i.e., reaction with the left hand; MEP
recorded at the right hand), a quadratic effect for the fac-
tor latency (T-quad(1,10) = 19.99; p < 0.005) was
obtained. MEPs were larger at an interval between S2 and
the TMS-pulse of 230 ms than at the other latencies under
study.
Nogo trials
Fig. 4 illustrates the significant statistical effects obtained
for nogo trials.
A highly significant linear effect resulted for the Med ×
Latency interaction (T-lin(1,10) = 23.05; p < 0.001):
Under MPH, MEP amplitudes increased with time
whereas, under placebo, they decreased (see Fig. 4a).
A specific test (post-hoc analysis) comparing the go-right
vs. nogo-right trials at the TMS latency of 120 ms revealed
a significant decrease of relative MEP amplitudes only for
MPH (48.2 ± 56.0%; F(1,10) = 6.41, p < 0.05) but not for
placebo (10.7 ± 42.8%; F(1,10) = 0.79, n.s.) indicating an
earlier inhibitory effect for MPH.
The Med × Pulse interaction also turned out to be signifi-
cant (F(1,10) = 5.74; p < 0.05). Accordingly, a medication
effect was obtained when considering the SICI, i.e., the
ratio of conditioned and unconditioned MEPs (F(1,10) =
5.35; p < 0.05): SICI was stronger under MPH (MPH: 41.3
± 20.0%; placebo: 58.5 ± 31.2%; see Fig. 4b).
Besides the effects concerning medication, other TMS
stimulus- or task-related effects were observed in nogo tri-
als. MEP amplitudes were higher when inhibiting
responses of the right hand compared to the left hand
(nogo-left: 52.8 ± 8.0%; nogo-right: 73.8 ± 26.3%; factor
Side: F(1,10) = 11.54; p < 0.01).
For the Latency × Pulse interaction, a highly significant
trend was obtained: With latency between S2 and TMS
pulse increasing, the difference between the amplitudes ofBehavioral and Brain Functions 2009, 5:12 http://www.behavioralandbrainfunctions.com/content/5/1/12
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Relative MEP amplitudes in control, go and nogo conditions Figure 3
Relative MEP amplitudes in control, go and nogo conditions. Relative MEP amplitudes ± SE in control (top), go (mid-
dle) and nogo conditions (bottom). The interval between the S2 stimulus and the TMS pulse in milliseconds is plotted against 
the x-axis ("latency"), the y-axis describes the resulting amplitude as percentage of the mean values of the respective control 
condition. Black: placebo, blue: MPH; filled squares: single-pulse responses, open squares: double-pulse responses (ISI 3 ms).
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single-pulse and double-pulse MEPs increased in a linear
fashion (T-lin(1,10) = 20.69; p < 0.001). Accordingly, a
Latency effect was obtained for the SICI (T-lin(1,10) =
9.70; p < 0.01; see Fig. 4c).
Compared to the other two latencies being measured (120
ms, 350 ms), the MEPs were significantly smaller at the
230 ms latency (factor Latency: T-quad(1,10) = 9.31; p <
0.05; see Fig. 4d).
Discussion
In previous TMS studies, the effects of MPH on motor sys-
tem excitability were investigated in a resting condition.
To our knowledge, this is the first study dealing with MPH
effects on motor system excitability in a response inhibi-
tion task requiring volitional inhibition and execution of
prepared motor responses. Using this approach, a distinct
pattern of excitatory and inhibitory effects could be
revealed.
Task paradigm
We used a S1-S2 paradigm and introduced a reward sys-
tem with a challenging time frame of 350 ms for the
response. The rather small standard deviations of the sub-
jects' mean reaction time and low number of impulsivity
errors (see Table 1) clearly indicate that all subjects tried
Statistical effects in nogo-trials Figure 4
Statistical effects in nogo-trials. Means ± SE are shown. Left-top: Highly significant medication × latency interaction effect. 
Under methylphenidate (MPH, blue squares), MEP amplitudes increase in the time range analyzed. In the placebo condition 
(black squares), the opposite behaviour can be seen. Right-top: Under MPH, short-interval intracortical inhibition (SICI) is 
smaller than in the placebo condition. Left-bottom: SICI decreases linearly from 120 ms to 350 ms. Right-bottom: MEP ampli-
tudes show a quadratic behaviour. They are smallest at latency 230 ms.
SICI – Medication: F(1,10) = 5.35, p<0.05 Medication x Latency: T-lin(1,10)=23.1; p<0.001
Latency: T-quad(1,10)=9.31; p<0.05
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to respond as fast and accurately as possible in order to
maximize their profit. Thus, the reward system provided
for well-defined test conditions. Otherwise, e.g., the MPH
effect on reaction time could not have been detected.
Additionally, it seems likely that the effort to inhibit the
prepared response were higher due to the reward system
[22].
Methodological aspects
TMS pulses were applied at 120 ms, 230 ms or 350 ms
after the S2 stimulus. These values were chosen according
to the N1, N2 and P300 components of event-related
potentials, which are related to inhibitory processes [23].
Of course, three different latencies provide only limited
information about temporal characteristics. But neverthe-
less, we could reveal a distinct pattern of excitatory and
inhibitory effects over time.
In nogo trials, SICI increased over the 350 ms latency
range. Thus, our results are in line with the study of Sohn
et al. indicating that SICI is actively involved in volitional
inhibition [21].
MEPs (recorded at the right m. abductor digiti minimi) in
nogo-right trials were larger than in nogo-left trials. A
selective activation in relation to the prepared response
(including spinal mechanisms) could have accounted for
this effect in our two-sided experiment [24,25]. But no sig-
nificant interaction effects containing the factor 'Side'
were obtained in the nogo condition. This finding indi-
cates that inhibitory effects occurred bilaterally. Neuroim-
aging studies have shown selective cortical activation
related to volitional inhibition in the prefrontal cortex
and supplementary motor cortex. Bilateral activation of
these areas may explain non-selective inhibition occurring
in nogo trials [21].
Over-all excitability and SICI developed differentially over
the latency range analyzed. Whereas linear effects were
observed for SICI, over-all excitability showed a quadratic
time course. This relation suggests that there is an inter-
play of different excitatory and inhibitory mechanisms
being involved in the execution and inhibition of a pre-
pared response [1].
MPH effects
The main objective of this study was to investigate the
MPH effects on motor system excitability and motor con-
trol, respectively.
Subjects reacted faster under MPH but not at the cost of
performance errors. Quite the contrary, there was a trend
towards fewer impulsivity errors under MPH. These effects
at the performance level may indicate improved motor
functions under stimulants as it had already been stated
by Rapoport et al. nearly 30 years ago [26].
For SICI, a condition-specific effect was found. Whereas
no significant effects were obtained in control and go tri-
als, SICI was significantly enhanced in nogo trials under
MPH (compared to placebo).
Besides this SICI increase, an earlier inhibitory effect (at
120 ms) and an increase of MEP amplitudes over time
under MPH were observed in nogo trials. So, effects on
motor system excitability during response inhibition were
of excitatory and inhibitory nature.
Relating this pattern of TMS effects to the functioning of a
car, it is not just the gas or the brake pedals which work
better. The effects of a single dose of MPH (20 mg) in
healthy adults may be best described as a car with a better
tuning.
Limitations of the study
Two left-handed subjects were included in the small sam-
ple which may have affected the results. However, the
same result pattern was obtained when analyzing the data
without the two left-handed subjects.
For data analysis, some assumptions were made (e.g.,
upper and lower MEP limits) which may have biased the
results. On the other hand, it seems unlikely that these
assumptions affected the placebo and the MPH results dif-
ferentially.
Conclusion
TMS allows to study dynamics of motor system excitabil-
ity in response inhibition tasks, reflecting a pattern of exci-
tatory and inhibitory effects. This pattern is indicated to
be significantly altered by MPH in healthy adults. Thus,
this neurophysiological approach could extend the spec-
trum of neurophysiological methods (in addition to
event-related potentials and functional neuroimaging
[23,27]) to investigate response inhibition, e.g., in chil-
dren and adults with ADHD.
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